Animal models of Charcot-Marie-Tooth disease type 1AM. W. Sereda, K. -A. Nave · 2006

Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathyFledrich, R.; Abdelaal, T.; Rasch, L.; Bansal, V.; Schütza, V.; Brügger, B.; Lüchtenborg, C.; Prukop, T.; Stenzel, J.; Rahman, R. U.; Hermes, D.; Ewers, D.; Möbius, W.; Ruhwedel, T.; Katona, I.; Weis, J.; Klein, D.; Martini, R.; Brück, W.; Müller, W. C.; Bonn, S.; Bechmann, I.; Nave, K. A.; Stassart, R. M.; Sereda, M. W. · Nature Communications · 2018